CoMMiTMenT confirmed

3rd CoMMiTMenT Progress Meeting in Roscoff, France

18 months into the CoMMiTMenT project, the Consortium gathered for its biannual progress meeting at Hotel Le Gulf Stream in Roscoff, France, from 15th to 16th April 2015. Work results as presented by the team members showed the remarkable progress made within CoMMiTMenT during the first project period. All achievements were actively discussed by the team and next steps to move forward towards the project goal determined. The Consortium was also very pleased to welcome Prof. Dr Ingolf Bernhardt from Saarland University as invited speaker, who gave an interesting lecture on important aspects of biological membranes and red blood cells, as well as Dr Stéphane Egée from the Station Biologique in Roscoff in his function as CoMMiTMenT Advisory Board member.
Since the meeting was directly followed by the 20th European Red Cell Society Meeting at Roscoff, Consortium members grasped the opportunity to participate in this important conference, where they could network with peers in red blood cell research and also promote the CoMMiTMenT project with presentations by the Project Coordinator, Dr Lars Kaestner (Saarland University), Consortium member Dr Anna Bogdanova (University Zürich) as well as junior researcher Rick Huisjes (Medical Centre Utrecht).
The next progress meeting has already been scheduled: it will take place in the UK in September 2015.

CoMMiTMenT is a five-year Collaborative Project funded by the European Commission under the 7th Framework Programme of the European Union. The project aims to develop combined imaging technologies based on optofluidic microscopy and scanning ion conductance microscopy. An integrated, completely simultaneous device named µCOSMOS will be used as a proof-of-principle for therapeutic interventions in rare anaemias.

Eurice is the management partner of CoMMiTMenT and contributes to the successful implementation of the project goals.

Your contact:
Christa Brettar
European Research and Project Office GmbH
Tel.: +49 681 9592 3375
Email

Further reading
The CoMMiTMenT consortium
The CoMMiTMenT consortium

Tags: FP7